Breaking News: Large Study Shows Measuring Medication Risk with MedWise® Can Help Reduce Premature Death
Click to learn what these findings mean for medication safety and practice

Daniel E Buffington, PharmD, MBA, FAPhA

Daniel E Buffington, PharmD, MBA, FAPhA
President and CEO at Clinical Pharmacology Services Inc.

Dr. Daniel Buffington is the President and Practice Director at Clinical Pharmacology Services, located in Tampa, FL. He is also on faculty at the University of South Florida Colleges of Medicine and Pharmacy.

He studied Biology & Biochemistry at the University of South Florida, completed the Doctor of Pharmacy (PharmD), and Master of Business Administration (MBA) from Mercer University. His postgraduate training included a Pharmacy Practice Residency and Clinical Pharmacology Fellowship at Emory University.

Dr. Buffington, is a clinical pharmacology specialist and provides medication therapy management consulting, serves as a principal investigator for Phase II and III clinical trials, and manages a national drug information service that provides clinical support for medical practices, health systems, and health plans. The practice also includes a forensic pharmacology division that supports medical examiners, law enforcement, and attorneys.

The practice focuses on patients taking chronic or high-risk medications and provides medication therapy management services to improve health outcomes and patient safety. He has served as the President of the Florida Society of Health-Systems Pharmacists (FSHP), is currently President-Elect of the Florida Pharmacy Association (FPA), Board of Trustees at the American Pharmacists Association’s (APhA) and represents pharmacists on the American Medical Association’s Current Procedural Terminology (CPT) Editorial Panel.